The limitations of highly active anti-retroviral therapy (HAART) have necessitated the development of alternative therapeutic strategies. One of the approaches that has gained prominence in recent years is therapeutic vaccination. We decided to assess the capacity of mature dendritic cells, derived from blood monocytes of HIV-1 infected patients, to generate functional T-cell responses. For this purpose, we constructed a chimeric mRNA encoding the proteins Tat, Rev and Nef. The TaReNef encoding information was linked to the HLA class II-targeting sequence of DC-LAMP. Broadly directed HIV-specific CD4(+) and CD8(+) cytotoxic T cells exhibiting a poly-functional cytokine secretion pattern were generated by co-culturing with autologous chimeri...
Dendritic cells (DC) are key phagocytic cells that play crucial roles in both the innate and adaptiv...
Recall T cell responses to HIV-1 antigens are used as a surrogate for endogenous cellular immune res...
BACKGROUND: Effective therapy for HIV-infected individuals remains an unmet medical need. Promising ...
Infection with human immunodeficiency virus type 1 (HIV-1) is characterized by dysfunction of HIV-1–...
Transfection with synthetic mRNA is a safe and efficient method of delivering antigens to dendritic ...
Background: In an effort to raise protective antiviral immunity, dendritic cell immunotherapy was ev...
Dendritic cells (DCs) are professional antigen-presenting cells of the immune system with the abilit...
The need for a therapeutic human immunodeficiency virus (HIV) vaccine is urgent for the control of t...
Developing an immunotherapy to keep human immunodeficiency virus type 1 (HIV-1) replication suppress...
T cells to a broad array of HIV-1 epitopes during ART. T cells specific for a much broader range an...
Background: During early HIV-1 infection, immunodominant T cell responses to highly variable epitope...
Background: HIV-1 eradication may require reactivation of latent virus along with stimulation of HIV...
During acute HIV-1 infection (AHI), CD8+ T cell responses are initially induced to only 1-3 viral e...
Copyright © 2012 Ellen Van Gulck et al. This is an open access article distributed under the Creativ...
HIV-1 remains sequestered during antiretroviral therapy (ART) and can resume high-level replication ...
Dendritic cells (DC) are key phagocytic cells that play crucial roles in both the innate and adaptiv...
Recall T cell responses to HIV-1 antigens are used as a surrogate for endogenous cellular immune res...
BACKGROUND: Effective therapy for HIV-infected individuals remains an unmet medical need. Promising ...
Infection with human immunodeficiency virus type 1 (HIV-1) is characterized by dysfunction of HIV-1–...
Transfection with synthetic mRNA is a safe and efficient method of delivering antigens to dendritic ...
Background: In an effort to raise protective antiviral immunity, dendritic cell immunotherapy was ev...
Dendritic cells (DCs) are professional antigen-presenting cells of the immune system with the abilit...
The need for a therapeutic human immunodeficiency virus (HIV) vaccine is urgent for the control of t...
Developing an immunotherapy to keep human immunodeficiency virus type 1 (HIV-1) replication suppress...
T cells to a broad array of HIV-1 epitopes during ART. T cells specific for a much broader range an...
Background: During early HIV-1 infection, immunodominant T cell responses to highly variable epitope...
Background: HIV-1 eradication may require reactivation of latent virus along with stimulation of HIV...
During acute HIV-1 infection (AHI), CD8+ T cell responses are initially induced to only 1-3 viral e...
Copyright © 2012 Ellen Van Gulck et al. This is an open access article distributed under the Creativ...
HIV-1 remains sequestered during antiretroviral therapy (ART) and can resume high-level replication ...
Dendritic cells (DC) are key phagocytic cells that play crucial roles in both the innate and adaptiv...
Recall T cell responses to HIV-1 antigens are used as a surrogate for endogenous cellular immune res...
BACKGROUND: Effective therapy for HIV-infected individuals remains an unmet medical need. Promising ...